When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 28 Hits
  • Search Condition : Filter (MeSH = Carcinoma, Hepatocellular / drug therapy*)
Species Resource
DNA material Human MDR1 cDNA (RDB01372) Cabozantinib reverses multidrug resistance of human hepatoma HepG2/adr cells by modulating the function of P-glycoprotein.
DNA material pCAG-HIVgp (RDB04394) , pCMV-VSV-G-RSV-Rev (RDB04393) 3β-hydroxysterol δ24-reductase on the surface of hepatitis C virus-related hepatocellular carcinoma cells can be a target for molecular targeting therapy.
Human and Animal Cells COS-7(RCB0539) An Alkynyl-Fucose Halts Hepatoma Cell Migration and Invasion by Inhibiting GDP-Fucose-Synthesizing Enzyme FX, TSTA3.
Human and Animal Cells Inhibitory effect of fucoidan on Huh7 hepatoma cells through downregulation of CXCL12.
Human and Animal Cells Improving Drug Penetrability with iRGD Leverages the Therapeutic Response to Sorafenib and Doxorubicin in Hepatocellular Carcinoma.
Human and Animal Cells An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer.
Human and Animal Cells FH535 suppresses the proliferation and motility of hepatocellular carcinoma cells.
Human and Animal Cells Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response.
Human and Animal Cells Evaluation of ERCC1 expression for cisplatin sensitivity in human hepatocellular carcinoma.
Human and Animal Cells Sorafenib and TRAIL have synergistic effect on hepatocellular carcinoma.
Human and Animal Cells Combining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitro.
Human and Animal Cells Additive effect of sirolimus and anti-death receptor 5 agonistic antibody against hepatocellular carcinoma.
Human and Animal Cells Comparative analysis of cell death induction by cisplatin and 5-FU in human oral squamous and hepatocellular carcinoma cell lines.
Human and Animal Cells Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib.
Human and Animal Cells Caffeine increases the antitumor effect of Cisplatin in human hepatocellular carcinoma cells.
Human and Animal Cells The Rho kinase inhibitor fasudil is involved in p53-mediated apoptosis in human hepatocellular carcinoma cells.
Human and Animal Cells Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma.
Human and Animal Cells Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma.
Human and Animal Cells Anticancer effects of residual powder from Barley-Shochu distillation remnants against the orthotopic xenograft mouse models of hepatocellular carcinoma in vivo.
Human and Animal Cells BMP4 administration induces differentiation of CD133+ hepatic cancer stem cells, blocking their contributions to hepatocellular carcinoma.